ClinicalTrials.gov
ClinicalTrials.gov Menu

Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00875940
Recruitment Status : Completed
First Posted : April 6, 2009
Last Update Posted : April 6, 2009
Sponsor:
Information provided by:
University of Cincinnati

Brief Summary:
The study hypothesis is that a quantitative index can be derived from Tc-99m myocardial perfusion scans that accurately identifies the presence of left ventricular hypertrophy and pulmonary hypertension. Echocardiography provides the reference standard.

Condition or disease Intervention/treatment
Pulmonary Hypertension Other: Diagnostic imaging procedures.

Study Type : Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography
Study Start Date : February 2008
Actual Primary Completion Date : January 2009

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Group 1
Patients having both Tc-99m perfusion scan and echocardiogram.
Other: Diagnostic imaging procedures.



Primary Outcome Measures :
  1. Sensitivity and specificity of quantitation of Tc-99m perfusion scans for identification of pulmonary hypertension. [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Hospital population having diagnostic testing.
Criteria

Inclusion Criteria:

  • Must have an interpretable Tc-99m myocardial perfusion scan and an interpretable echocardiogram.

Exclusion Criteria:

  • Technically inadequate noninvasive test.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00875940


Locations
United States, Ohio
University of Cincinnati
Cincinnati, Ohio, United States, 45267
Sponsors and Collaborators
University of Cincinnati

Responsible Party: Myron Gerson M.D., University Internal Medicine Associates
ClinicalTrials.gov Identifier: NCT00875940     History of Changes
Other Study ID Numbers: IRB # 08-01-24-02
First Posted: April 6, 2009    Key Record Dates
Last Update Posted: April 6, 2009
Last Verified: April 2009

Additional relevant MeSH terms:
Hypertension
Hypertension, Pulmonary
Hypertrophy
Hypertrophy, Right Ventricular
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Pathological Conditions, Anatomical
Cardiomegaly
Heart Diseases